Biotech
Biotech Development and Scale-Up Plan
Named deliverable Lab-to-Plant Decision Plan
We start with the process as it exists today: the organism or assay, operating conditions, analytical methods, yields, variability, and the evidence behind them. I trace which assumptions are likely to break as scale changes and identify the experiments or measurements needed before the next investment. When the data supports it, the plan can include material balances, process alternatives, and inputs for a later techno-economic analysis. Detailed equipment design and engineering approval stay with the appropriate engineering team.
What you get
- A current-state process and evidence map
- A list of assumptions that have not yet been demonstrated
- Scale-dependent technical risks and likely failure points
- Data-quality and analytical-method gaps
- A focused experiment and measurement plan
- Decision gates for bench, pilot, partner, or manufacturing work
- Process alternatives with the tradeoffs that matter at the next scale
- Inputs needed for later equipment design or techno-economic analysis
- A proceed, test further, redirect, partner, or stop recommendation
Who it's for
Biotech teams with a real result and a pending process-development, pilot, manufacturing, or investment decision